Advanced search
Publication Cover
Expert Review of Clinical Immunology Volume 9, 2013 - Issue 4
Submit an article Journal homepage
280
Views
7
CrossRef citations to date
0
Altmetric
Perspective

Systems level immune response analysis and personalized medicine

Petter Brodin Center for Allogeneic Stem Cell Transplantation, CAST, Karolinska University Hospital, Huddinge, Sweden; Division of Therapeutic Immunology, Department of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden; Department of Microbiology, Tumor and Cell Biology, Karolinska Institute, Stockholm, Sweden
,
Davide Valentini Center for Allogeneic Stem Cell Transplantation, CAST, Karolinska University Hospital, Huddinge, Sweden; Division of Therapeutic Immunology, Department of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden
,
Michael Uhlin Center for Allogeneic Stem Cell Transplantation, CAST, Karolinska University Hospital, Huddinge, Sweden; Division of Therapeutic Immunology, Department of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden
,
Jonas Mattsson Center for Allogeneic Stem Cell Transplantation, CAST, Karolinska University Hospital, Huddinge, Sweden; Division of Therapeutic Immunology, Department of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden
,
Alimuddin Zumla Department of Infection, University College London Medical School, Windeyer Institute of Medical Sciences, London, UK
&
Markus J Maeurer Center for Allogeneic Stem Cell Transplantation, CAST, Karolinska University Hospital, Huddinge, Sweden. [email protected]; Division of Therapeutic Immunology, Department of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden; Department of Microbiology, Tumor and Cell Biology, Karolinska Institute, Stockholm, Sweden
Pages 307-317 | Published online: 10 Jan 2014

References

  • Vidal M, Cusick ME, Barabási AL. Interactome networks and human disease. Cell 144(6), 986–998 (2011).
  • Michaud M, Martins I, Sukkurwala AQ et al. Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice. Science 334(6062), 1573–1577 (2011).
  • Chuang HY, Hofree M, Ideker T. A decade of systems biology. Annu. Rev. Cell Dev. Biol. 26, 721–744 (2010).
  • Schadt EE, Friend SH, Shaywitz DA. A network view of disease and compound screening. Nat. Rev. Drug Discov. 8(4), 286–295 (2009).
  • Hood L, Friend SH. Predictive, personalized, preventive, participatory (P4) cancer medicine. Nat. Rev. Clin. Oncol. 8(3), 184–187 (2011).
  • Genomes Project C. A map of human genome variation from population-scale sequencing. Nature 467(7319), 1061–1073 (2010).
  • Sudmant PH, Kitzman JO, Antonacci F et al.; 1000 Genomes Project. Diversity of human copy number variation and multicopy genes. Science 330(6004), 641–646 (2010).
  • Segata N, Waldron L, Ballarini A, Narasimhan V, Jousson O, Huttenhower C. Metagenomic microbial community profiling using unique clade-specific marker genes. Nat. Methods 9(8), 811–814 (2012).
  • Human Microbiome Project C. A framework for human microbiome research. Nature 486(7402), 215–221 (2012).
  • Yatsunenko T, Rey FE, Manary MJ et al. Human gut microbiome viewed across age and geography. Nature 486(7402), 222–227 (2012).
  • Alizadeh AA, Eisen MB, Davis RE et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403(6769), 503–511 (2000).
  • Bullinger L, Döhner K, Bair E et al. Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia. N. Engl. J. Med. 350(16), 1605–1616 (2004).
  • Druker BJ, Tamura S, Buchdunger E et al. Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells. Nat. Med. 2(5), 561–566 (1996).
  • O’Day SJ, Hamid O, Urba WJ. Targeting cytotoxic T-lymphocyte antigen-4 (CTLA-4): a novel strategy for the treatment of melanoma and other malignancies. Cancer 110(12), 2614–2627 (2007).
  • Waterhouse P, Penninger JM, Timms E et al. Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science 270(5238), 985–988 (1995).
  • Wölfel T, Hauer M, Schneider J et al. A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma. Science 269(5228), 1281–1284 (1995).
  • Takenoyama M, Baurain JF, Yasuda M et al. A point mutation in the NFYC gene generates an antigenic peptide recognized by autologous cytolytic T lymphocytes on a human squamous cell lung carcinoma. Int. J. Cancer 118(8), 1992–1997 (2006).
  • Chen YT. Cancer vaccine: identification of human tumor antigens by SEREX. Cancer J. 6(Suppl. 3), S208–S217 (2000).
  • Heller A, Zörnig I, Müller T et al. Immunogenicity of SEREX-identified antigens and disease outcome in pancreatic cancer. Cancer Immunol. Immunother. 59(9), 1389–1400 (2010).
  • Jäger E, Chen YT, Drijfhout JW et al. Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes. J. Exp. Med. 187(2), 265–270 (1998).
  • Chang YJ, Kim HY, Albacker LA et al. Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity. Nat. Immunol. 12(7), 631–638 (2011).
  • Hayday AC, Peakman M. The habitual, diverse and surmountable obstacles to human immunology research. Nat. Immunol. 9(6), 575–580 (2008).
  • Davis MM. A prescription for human immunology. Immunity 29(6), 835–838 (2008).
  • Rai D, Pham NL, Harty JT, Badovinac VP. Tracking the total CD8 T cell response to infection reveals substantial discordance in magnitude and kinetics between inbred and outbred hosts. J. Immunol. 183(12), 7672–7681 (2009).
  • Birmingham DJ, Rovin BH, Yu CY, Hebert LA. Of mice and men: the relevance of the mouse to the study of human SLE. Immunol. Res. 24(2), 211–224 (2001).
  • Venter JC, Adams MD, Myers EW et al. The sequence of the human genome. Science 291(5507), 1304–1351 (2001).
  • Lander ES, Linton LM, Birren B et al.; International Human Genome Sequencing Consortium. Initial sequencing and analysis of the human genome. Nature 409(6822), 860–921 (2001).
  • Eckhardt F, Beck S, Gut IG, Berlin K. Future potential of the Human Epigenome Project. Expert Rev. Mol. Diagn. 4(5), 609–618 (2004).
  • Pollack A. Huge genome project is proposed to fight cancer. New York Times, 28th March (2005).
  • Uhlén M, Björling E, Agaton C et al. A human protein atlas for normal and cancer tissues based on antibody proteomics. Mol. Cell Proteomics 4(12), 1920–1932 (2005).
  • Brodin P, Kärre K, Höglund P. NK cell education: not an on-off switch but a tunable rheostat. Trends Immunol. 30(4), 143–149 (2009).
  • Grossman Z, Paul WE. Self-tolerance: context dependent tuning of T cell antigen recognition. Semin. Immunol. 12(3), 197–203; discussion 257 (2000).
  • Chang S, Yang L, Moon YM et al. Anti-nuclear antibody reactivity in lupus may be partly hard-wired into the primary B-cell repertoire. Mol. Immunol. 46(16), 3420–3426 (2009).
  • Querec TD, Akondy RS, Lee EK et al. Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans. Nat. Immunol. 10(1), 116–125 (2009).
  • Nakaya HI, Wrammert J, Lee EK et al. Systems biology of vaccination for seasonal influenza in humans. Nat. Immunol. 12(8), 786–795 (2011).
  • Northrup DL, Zhao K. Application of ChIP-Seq and related techniques to the study of immune function. Immunity 34(6), 830–842 (2011).
  • Ornatsky O, Bandura D, Baranov V, Nitz M, Winnik MA, Tanner S. Highly multiparametric analysis by mass cytometry. J. Immunol. Methods 361(1–2), 1–20 (2010).
  • Bendall SC, Nolan GP, Roederer M, Chattopadhyay PK. A deep profiler’s guide to cytometry. Trends Immunol. 33(7), 323–332 (2012).
  • Newell EW, Sigal N, Bendall SC, Nolan GP, Davis MM. Cytometry by time-of-flight shows combinatorial cytokine expression and virus-specific cell niches within a continuum of CD8(+) T cell phenotypes. Immunity 36(1), 142–152 (2012).
  • Bendall SC, Simonds EF, Qiu P et al. Single-cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum. Science 332(6030), 687–696 (2011).
  • Pala P, Hussell T, Openshaw PJ. Flow cytometric measurement of intracellular cytokines. J. Immunol. Methods 243(1–2), 107–124 (2000).
  • Alter G, Malenfant JM, Altfeld M. CD107a as a functional marker for the identification of natural killer cell activity. J. Immunol. Methods 294(1–2), 15–22 (2004).
  • Krutzik PO, Nolan GP. Intracellular phospho-protein staining techniques for flow cytometry: monitoring single cell signaling events. Cytometry. A 55(2), 61–70 (2003).
  • Chaussabel D, Pascual V, Banchereau J. Assessing the human immune system through blood transcriptomics. BMC Biol. 8, 84 (2010).
  • Brighenti S, Andersson J. Local immune responses in human tuberculosis: learning from the site of infection. J. Infect. Dis. 205(Suppl. 2), S316–S324 (2012).
  • Rahman S, Gudetta B, Fink J et al. Compartmentalization of immune responses in human tuberculosis: few CD8+ effector T cells but elevated levels of FoxP3+ regulatory T cells in the granulomatous lesions. Am. J. Pathol. 174(6), 2211–2224 (2009).
  • Jäger E, Maeurer M, Höhn H et al. Clonal expansion of Melan A-specific cytotoxic T lymphocytes in a melanoma patient responding to continued immunization with melanoma-associated peptides. Int. J. Cancer 86(4), 538–547 (2000).
  • Won JH, Goldberger O, Shen-Orr SS, Davis MM, Olshen RA. Significance analysis of xMap cytokine bead arrays. Proc. Natl Acad. Sci. USA 109(8), 2848–2853 (2012).
  • Altman JD, Moss PA, Goulder PJ et al. Phenotypic analysis of antigen-specific T lymphocytes. Science 274(5284), 94–96 (1996).
  • Davis MM, Altman JD, Newell EW. Interrogating the repertoire: broadening the scope of peptide-MHC multimer analysis. Nat. Rev. Immunol. 11(8), 551–558 (2011).
  • Gaseitsiwe S, Valentini D, Mahdavifar S et al. Pattern recognition in pulmonary tuberculosis defined by high content peptide microarray chip analysis representing 61 proteins from M. tuberculosis. PLoS ONE 3(12), e3840 (2008).
  • Valentini D, Gaseitsiwe S, Maeurer M. Humoral ‘reactome’ profiles using peptide microarray chips. Trends Immunol. 31(11), 399–400 (2010).
  • Yang XP, Ghoreschi K, Steward-Tharp SM et al. Opposing regulation of the locus encoding IL-17 through direct, reciprocal actions of STAT3 and STAT5. Nat. Immunol. 12(3), 247–254 (2011).
  • Mold JE, Venkatasubrahmanyam S, Burt TD et al. Fetal and adult hematopoietic stem cells give rise to distinct T cell lineages in humans. Science 330(6011), 1695–1699 (2010).
  • Galli SJ, Borregaard N, Wynn TA. Phenotypic and functional plasticity of cells of innate immunity: macrophages, mast cells and neutrophils. Nat. Immunol. 12(11), 1035–1044 (2011).
  • Akbar AN, Henson SM. Are senescence and exhaustion intertwined or unrelated processes that compromise immunity? Nat. Rev. Immunol. 11(4), 289–295 (2011).
  • Chen R, Mias GI, Li-Pook-Than J et al. Personal omics profiling reveals dynamic molecular and medical phenotypes. Cell 148(6), 1293–1307 (2012).
  • Almqvist C, Adami HO, Franks PW et al. LifeGene–a large prospective population-based study of global relevance. Eur. J. Epidemiol. 26(1), 67–77 (2011).
  • Maeurer M. Markus Maeurer on the LifeGene project. Expert Rev. Clin. Immunol. 6(5), 709–712 (2010).
  • Dawood FS, Jain S, Finelli L et al. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N. Engl. J. Med. 360(25), 2605–2615 (2009).
  • Perez-Padilla R, de la Rosa-Zamboni D, Ponce de Leon S et al.; INER Working Group on Influenza. Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N. Engl. J. Med. 361(7), 680–689 (2009).
  • Cao B, Li XW, Mao Y et al.; National Influenza A Pandemic (H1N1) 2009 Clinical Investigation Group of China. Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China. N. Engl. J. Med. 361(26), 2507–2517 (2009).
  • Belser JA, Wadford DA, Pappas C et al. Pathogenesis of pandemic influenza A (H1N1) and triple-reassortant swine influenza A (H1) viruses in mice. J. Virol. 84(9), 4194–4203 (2010).
  • Henter JI, Palmkvist-Kaijser K, Holzgraefe B, Bryceson YT, Palmér K. Cytotoxic therapy for severe swine flu A/H1N1. Lancet 376(9758), 2116 (2010).
  • Jamieson AM, Yu S, Annicelli CH, Medzhitov R. Influenza virus-induced glucocorticoids compromise innate host defense against a secondary bacterial infection. Cell Host Microbe 7(2), 103–114 (2010).
  • Shapira SD, Gat-Viks I, Shum BO et al. A physical and regulatory map of host–influenza interactions reveals pathways in H1N1 infection. Cell 139(7), 1255–1267 (2009).
  • Nohynek H, Jokinen J, Partinen M et al. AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland. PLoS ONE 7(3), e33536 (2012).
  • Partinen M, Saarenpää-Heikkilä O, Ilveskoski I et al. Increased incidence and clinical picture of childhood narcolepsy following the 2009 H1N1 pandemic vaccination campaign in Finland. PLoS ONE 7(3), e33723 (2012).
  • Hor H, Kutalik Z, Dauvilliers Y et al. Genome-wide association study identifies new HLA class II haplotypes strongly protective against narcolepsy. Nat. Genet. 42(9), 786–789 (2010).
  • Dauvilliers Y, Montplaisir J, Cochen V et al. Post-H1N1 narcolepsy-cataplexy. Sleep 33(11), 1428–1430 (2010).
  • Mendes MF, Valladares Neto Dde C, Azevedo RA, Caramelli P. Narcolepsy after A/H1N1 vaccination. Clinics (Sao. Paulo). 67(1), 77–78 (2012).
  • Broughton R, Ghanem Q, Hishikawa Y, Sugita Y, Nevsimalova S, Roth B. Life effects of narcolepsy in 180 patients from North America, Asia and Europe compared to matched controls. Can. J. Neurol. Sci. 8(4), 299–304 (1981).
  • Karjalainen J, Salmela P, Ilonen J, Surcel HM, Knip M. A comparison of childhood and adult type I diabetes mellitus. N. Engl. J. Med. 320(14), 881–886 (1989).
  • Lammi N, Taskinen O, Moltchanova E et al. A high incidence of Type 1 diabetes and an alarming increase in the incidence of Type 2 diabetes among young adults in Finland between 1992 and 1996. Diabetologia 50(7), 1393–1400 (2007).
  • Thunander M, Petersson C, Jonzon K et al. Incidence of type 1 and type 2 diabetes in adults and children in Kronoberg, Sweden. Diabetes Res. Clin. Pract. 82(2), 247–255 (2008).
  • Sutcliffe JG, de Lecea L. The hypocretins: excitatory neuromodulatory peptides for multiple homeostatic systems, including sleep and feeding. J. Neurosci. Res. 62(2), 161–168 (2000).
  • Lin L, Faraco J, Li R et al. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 98(3), 365–376 (1999).
  • Peyron C, Faraco J, Rogers W et al. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat. Med. 6(9), 991–997 (2000).
  • Thannickal TC, Moore RY, Nienhuis R et al. Reduced number of hypocretin neurons in human narcolepsy. Neuron 27(3), 469–474 (2000).
  • Black JL 3rd, Silber MH, Krahn LE et al. Analysis of hypocretin (orexin) antibodies in patients with narcolepsy. Sleep 28(4), 427–431 (2005).
  • Gledhill RF, Bartel PR, Yoshida Y, Nishino S, Scammell TE. Narcolepsy caused by acute disseminated encephalomyelitis. Arch. Neurol. 61(5), 758–760 (2004).
  • Cvetkovic-Lopes V, Bayer L, Dorsaz S et al. Elevated Tribbles homolog 2-specific antibody levels in narcolepsy patients. J. Clin. Invest. 120(3), 713–719 (2010).
  • Toyoda H, Tanaka S, Miyagawa T, Honda Y, Tokunaga K, Honda M. Anti-Tribbles homolog 2 autoantibodies in Japanese patients with narcolepsy. Sleep 33(7), 875–878 (2010).
  • Hallmayer J, Faraco J, Lin L et al. Narcolepsy is strongly associated with the T-cell receptor α locus. Nat. Genet. 41(6), 708–711 (2009).
  • Himmerich H, Beitinger PA, Fulda S et al. Plasma levels of tumor necrosis factor α and soluble tumor necrosis factor receptors in patients with narcolepsy. Arch. Intern. Med. 166(16), 1739–1743 (2006).
  • Butterfield LH, Disis ML, Khleif SN, Balwit JM, Marincola FM. Immuno-oncology biomarkers 2010 and beyond: perspectives from the iSBTc/SITC biomarker task force. J. Transl. Med. 8, 130 (2010).
  • Fox BA, Schendel DJ, Butterfield LH et al. Defining the critical hurdles in cancer immunotherapy. J. Transl. Med. 9(1), 214 (2011).
  • Hodi FS, O’Day SJ, McDermott DF et al. Improved survival with ipilimumab in patients with metastatic melanoma. N. Engl. J. Med. 363(8), 711–723 (2010).
  • Newell EW, Sigal N, Bendall SC, Nolan GP, Davis MM. Cytometry by time-of-flight shows combinatorial cytokine expression and virus-specific cell niches within a continuum of CD8+ T cell phenotypes. Immunity 36(1), 142–152 (2012).
  • Lundmark F, Duvefelt K, Iacobaeus E et al. Variation in interleukin 7 receptor α chain (IL7R) influences risk of multiple sclerosis. Nat. Genet. 39(9), 1108–1113 (2007).
  • Gregory SG, Schmidt S, Seth P et al.; Multiple Sclerosis Genetics Group. Interleukin 7 receptor α chain (IL7R) shows allelic and functional association with multiple sclerosis. Nat. Genet. 39(9), 1083–1091 (2007).
  • Hafler DA, Compston A, Sawcer S et al.; International Multiple Sclerosis Genetics Consortium. Risk alleles for multiple sclerosis identified by a genome-wide study. N. Engl. J. Med. 357(9), 851–862 (2007).
  • Turnbaugh PJ, Hamady M, Yatsunenko T et al. A core gut microbiome in obese and lean twins. Nature 457(7228), 480–484 (2009).

Website

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.